UBS Reiterates Neutral Rating on RXO, Inc. (RXO)

June 20, 2024 6:09 AM

UBS analyst Tom Wadewitz reiterated a Neutral rating and $22.00 price target on RXO, Inc. (NYSE: RXO).The analyst comments "On ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found